Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05075174
Other study ID # RECHMPL21_0564
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 1, 2020
Est. completion date June 1, 2022

Study information

Verified date September 2021
Source University Hospital, Montpellier
Contact Noémie Ranisavljevic, M.D., Ph.D
Phone 06 37 10 89 38
Email n-ranisavljevic@chu-montpellier.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Progesterone level has been studied at days before embryo transfert. But, progesterone blood level has not been studied 15 days after embryo transfert. The aim of this study is to study progesterone level impact at 15 days after embryo transfert on evolving pregnanies or early miscarriages.


Recruitment information / eligibility

Status Recruiting
Enrollment 540
Est. completion date June 1, 2022
Est. primary completion date September 1, 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 43 Years
Eligibility Inclusion criteria: - ART program in Montpellier hospital - age >18 years old - Blood progesterone level 15 days after embryo transfert - Pregnancy development know Exclusion criteria: - non uterine pregnancy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Uhmontpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary number of blood progesterone blood progesterone at day 15 after embryo transfert 1 day
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Not yet recruiting NCT03120884 - Intracytoplasmic Sperm Injection in Non-male Factor Infertility in Advanced Maternal Age N/A
Recruiting NCT03421314 - Effect of Zinc and Selenium Supplementation on HIV+ Individuals on Antiretroviral Treatment. N/A
Completed NCT04546412 - Importance of the Microtubule Cytoskeleton in Oocyte Competence
Completed NCT03343938 - Evaluation of a Closed Assisted Reproductive Technology (ART) Station Versus an Open Flow Cabinet N/A
Completed NCT03808194 - Lotto to Link Study: A Prospective, Interventional, Randomized Study of Conditional Incentives N/A
Active, not recruiting NCT04910711 - Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV Phase 4
Completed NCT04714255 - Efficacy of Art Intervention on Decreasing Pain and Anxiety During Intravenous Cannulation N/A
Recruiting NCT03804294 - Effect of Vitamin D on Outcome of Assisted Reproductive Technology(ART);
Recruiting NCT05090150 - The SMART ART Study N/A
Recruiting NCT05358678 - Cesarean Section Scar Niche: The Impact on ART Outcome
Completed NCT02929992 - Delivery Optimization for Antiretroviral Therapy (The DO ART Study) N/A
Recruiting NCT05528536 - Acceptance and Commitment Therapy and Exercise for Older Adults With Chronic Pain N/A
Completed NCT04396210 - Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic
Completed NCT05053178 - The Effect of Mindfulness-Based Mandala Activity on Anxiety and Spiritual Well-Being Levels of Senior Nursing Students N/A
Not yet recruiting NCT06334003 - Cardiometabolic Function in Offspring, Mother and Placenta After Assisted Reproductive Technology
Recruiting NCT05962775 - Ethanol Sclerotherapy Prior to ART N/A
Completed NCT03611907 - Comparing Two Types of Needle for Oocytes Retrieval N/A